This study is testing a treatment for liver cancer called Hepatocellular Carcinoma (HCC). The treatment uses Eye90 Microspheres™, which are tiny beads filled with a radioactive substance called yttrium-90 (Y-90). This helps give targeted radiation to the liver tumor. To join, you must be over 18, have a specific type of liver cancer confirmed by tests, and be healthy in certain ways. You can't join if you have some blood issues, poor liver function, or if cancer has spread outside the liver. Platelets are tiny blood cells that help you stop bleeding, and INR is a number that tells how well your blood clots. If these numbers are abnormal, you might not be eligible.

• The study aims to treat all cancer spots in one session.
• Participants need a life expectancy of at least 6 months.
• The study is open-label, meaning both doctors and participants know what treatment is given.